RALOXIFENE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Raloxifene Hydrochloride, and when can generic versions of Raloxifene Hydrochloride launch?
Raloxifene Hydrochloride is a drug marketed by Amneal Pharms, Aurobindo Pharma, Cadila Pharms Ltd, Glenmark Pharms Ltd, Invagen Pharms, Sciegen Pharms Inc, Teva Pharms Usa, and Watson Labs Inc. and is included in eight NDAs.
The generic ingredient in RALOXIFENE HYDROCHLORIDE is raloxifene hydrochloride. There are seventeen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Raloxifene Hydrochloride
A generic version of RALOXIFENE HYDROCHLORIDE was approved as raloxifene hydrochloride by TEVA PHARMS USA on March 4th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RALOXIFENE HYDROCHLORIDE?
- What are the global sales for RALOXIFENE HYDROCHLORIDE?
- What is Average Wholesale Price for RALOXIFENE HYDROCHLORIDE?
Summary for RALOXIFENE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 17 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 86 |
| Patent Applications: | 3,488 |
| DailyMed Link: | RALOXIFENE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for RALOXIFENE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| German University in Cairo | Phase 2 |
| Cairo University | Phase 2 |
| University of Houston | N/A |
Pharmacology for RALOXIFENE HYDROCHLORIDE
| Drug Class | Estrogen Agonist/Antagonist |
| Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for RALOXIFENE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for RALOXIFENE HYDROCHLORIDE
US Patents and Regulatory Information for RALOXIFENE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms | RALOXIFENE HYDROCHLORIDE | raloxifene hydrochloride | TABLET;ORAL | 208206-001 | Apr 8, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms Usa | RALOXIFENE HYDROCHLORIDE | raloxifene hydrochloride | TABLET;ORAL | 078193-001 | Mar 4, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Glenmark Pharms Ltd | RALOXIFENE HYDROCHLORIDE | raloxifene hydrochloride | TABLET;ORAL | 204491-001 | Mar 22, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs Inc | RALOXIFENE HYDROCHLORIDE | raloxifene hydrochloride | TABLET;ORAL | 200825-001 | Jan 21, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
